Mascha Binder
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 14
- Immunology 30
- Immunotherapy and Immune Responses 13
- Co-authors
- Lisa Paschold (31 shared papers)Edith Willscher (21 shared papers)Christoph Schultheiß (34 shared papers)Martin Trepel (15 shared papers)Carsten Bokemeyer (27 shared papers)Friederike Braig (8 shared papers)Moshe Arditi (3 shared papers)Rebecca A. Porritt (3 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (9 papers)Frontiers in Oncology (4 papers)Haematologica (4 papers)Oncotarget (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Mascha Binder
130 papers receiving 2.9k citations
Mascha Binder's Hit Papers
Peers
Comparison fields: 5 of 116
- Genetics 392
- Hematology 340
- Oncology 795
- Neurology 404
- Infectious Diseases 482
Countries citing papers authored by Mascha Binder
This map shows the geographic impact of Mascha Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mascha Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mascha Binder more than expected).
Fields of papers citing papers by Mascha Binder
This network shows the impact of papers produced by Mascha Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mascha Binder. The network helps show where Mascha Binder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mascha Binder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 Hit paper breakdown → | 2022 | 267 |
| 2 | 2020 | 216 | |
| 3 | 2016 | 204 | |
| 4 | 2018 | 113 | |
| 5 | 2021 | 106 | |
| 6 | Core-binding factor: a central player in hematopoiesis and leukemia. | 1999 | 98 |
| 7 | 2006 | 95 | |
| 8 | 2021 | 90 | |
| 9 | 2012 | 87 | |
| 10 | 2017 | 86 | |
| 11 | 2019 | 66 | |
| 12 | 2010 | 62 | |
| 13 | 2017 | 57 | |
| 14 | 2016 | 55 | |
| 15 | 2022 | 53 | |
| 16 | 2015 | 51 | |
| 17 | 2019 | 49 | |
| 18 | 2019 | 44 | |
| 19 | 2020 | 44 | |
| 20 | 2016 | 44 |
About Mascha Binder
Mascha Binder is a scholar working on Oncology, Immunology, Genetics, Hematology and Molecular Biology, having authored 140 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (13 papers), Multiple Myeloma Research and Treatments (13 papers), Lymphoma Diagnosis and Treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). The work is most often cited by research in Genetics (392 citations), Hematology (340 citations), Oncology (795 citations), Neurology (404 citations) and Infectious Diseases (482 citations). Mascha Binder has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Lisa Paschold, Edith Willscher, Christoph Schultheiß, Martin Trepel, Carsten Bokemeyer, Friederike Braig, Moshe Arditi, Rebecca A. Porritt, Magali Noval Rivas and Anna Brandt. Their work appears in journals such as Blood, Journal of Clinical Oncology, Frontiers in Oncology, Haematologica and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.